1. Home
  2. TTSH vs ACIU Comparison

TTSH vs ACIU Comparison

Compare TTSH & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tile Shop Holdings Inc.

TTSH

Tile Shop Holdings Inc.

HOLD

Current Price

$4.10

Market Cap

279.3M

Sector

Finance

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.02

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTSH
ACIU
Founded
1985
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.3M
213.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TTSH
ACIU
Price
$4.10
$3.02
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
696.6K
1.4M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$338,787,000.00
$5,482,957.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$738.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$1.43
52 Week High
$7.75
$4.00

Technical Indicators

Market Signals
Indicator
TTSH
ACIU
Relative Strength Index (RSI) 15.05 50.19
Support Level $6.41 $2.87
Resistance Level $7.45 $3.45
Average True Range (ATR) 0.38 0.31
MACD -0.27 0.03
Stochastic Oscillator 13.10 38.09

Price Performance

Historical Comparison
TTSH
ACIU

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: